Our Mission

Our Mission & Vision

The ANZCCP is a professional membership body for cannabinoid medicine practitioners. Our vision is to guide the practice of Cannabinoid Medicine and better the lives of patients.

Our Objectives

  • Patient-centred clinical perspectives to the entire medical cannabis eco-system
  • Accredited clinician education and promote professional standards for the practice of cannabinoid medicine
  • Resources for practitioner support, advocacy and collegiality
  • Policy advice
  • Support for research

ANZCCP Founders

Dr Orit Holtzman


Dr Orit holds a Bachelor of Science in biology and psychology from the University of Tel Aviv, a PhD in neuroscience from the University of NSW and an MBBS from the Sydney Medical School at the University of Sydney. After working in the public hospital system, she began exploring wholistic health solutions and become passionate about utilising medicinal cannabis as a therapeutic agent. She began prescribing cannabis in 2019 and now has more than 400 patients that have been prescribed medicinal cannabis for various indications under her care, and is an authorised prescriber for multiple conditions.

Dr Gull Herzberg

Vice President

Dr Gull has been working as an Integrative medical practitioner since 2002. He has always been keen to explore investigative and therapeutic avenues complementary to those regularly used by his medical colleagues. He has been prescribing medicinal cannabis since 2016 for a wide range of conditions including, but not limited to chronic pain, MS and spasticity related symptoms, neuropathic pain, sleep disturbances, CINV and PTSD.

Dr John Teh

Founding board member

Dr John Teh Medical Director and Educator of PlantMed Medical Cannabis Clinic has been working within the Medicinal Cannabis industry since the legalisation of cannabis for medicinal use in Australia in February 2016.

Dr Imran Khan

Founding board member

Dr Imran Khan completed his medical training at The Sheffield School of Medicine (UK) in 2001. He has held clinical leadership roles in the UK, Australia & Qatar and is currently the Medical Director of Warringah Medical Centre (NSW). He is a UK trained Family Medical Practitioner, an advocate for the therapeutic use of medicinal cannabis. He is an ‘Authorised Prescriber’ of medicinal cannabis (approved by the TGA) and an educator in the field.

Lisa Dick

Board member

Lisa Dick has been a registered nurse for over 30 years, specialising in aged care, community health, urological conditions, chronic disease, pain and continence management. Lisa was endorsed as a Nurse Practitioner in 2016 after completing her Masters of Nurse Practitioner at The University of Melbourne. She has worked as a Nurse Practitioner in a variety of different settings including in both public and private health services. Lisa is a member of the Australian College of Nurse Practitioners (ACNP). During her career Lisa has been honoured to represent the ACNP as the Victorian Chapter Chair for a 2 year term. In 2021 Lisa commenced specialising in medicinal cannabis. She has always had an interest in plant-based medicine and since she was given the opportunity to provide treatment with whole plant products, there has been no looking back. Lisa enjoys every opportunity to attend and participate in educational events on Medicinal Cannabis and often presents at ACNP Conferences to her fellow colleagues.

Adele Hosseini

Adele Hosseini

Board member

Dr. Adele Hosseini is a pharmacist with a PhD and over 25 years of experience in leadership, global clinical research, regulatory affairs and university lecturing, with exposure across pharmaceuticals, clinical research organisation, medical devices, and academia. Pioneering across various industries in Australia including medicinal cannabis and psychedelics industry led Bod Australia’s Medical Advisory Board and research program and is a member of the board of directors of a Canadian medicinal cannabis company. Over the last few years, Dr. Hosseini has developed a deep understanding of medicinal cannabis and continues to development new strategic directions and development of clinical trials and programs for pharmaceutical cannabis for multiple therapeutic indications for public health benefit. She is an active industry contributor helping to build knowledge and shape the direction and future of the global pharmaceutical medicinal cannabis industry.

ANZCCP Advisors

Prof. Ian Brighthope

Following his medical training, he travelled widely throughout Europe, North America and Asia searching for solutions to the problems created by the significant gaps he recognised in the medical training of doctors. The Brighthope Clinics and Biocentres were developed in the 1970’s and specialised in Nutritional, Environmental and Herbal Medicine. As chairman of the Australian College of Herbal Medicine, he developed an early medicinal interest in cannabis and other herbs. As founding president of Australasian College of Nutritional and Environmental Medicine (ACNEM) for over 26 years, Professor Brighthope pioneered the first post-graduate medical course in nutrition in Australia. He is now the official ambassador of ACNEM and has acted as an advocate for doctors practicing Integrative Medicine for over 35 years.  He has had training and extensive experience in Crisis Management, Risk Management and Public/Government Relations.  He has also had extensive experience in the pharmaceutical manufacturing and exporting industry as the managing director of a TGA licensed facility.